首页> 外文学位 >Allosteric, mechanistic, and inhibitory investigations of human platelet 12-lipoxygenase, human reticulocyte 15-lipoxygenase-1 and human epithelial 15-lipoxygenase-2.
【24h】

Allosteric, mechanistic, and inhibitory investigations of human platelet 12-lipoxygenase, human reticulocyte 15-lipoxygenase-1 and human epithelial 15-lipoxygenase-2.

机译:人血小板12-脂氧合酶,人网织细胞15-脂氧合酶-1和人上皮15-脂氧合酶-2的变构,机理和抑制研究。

获取原文
获取原文并翻译 | 示例

摘要

The research presented in this dissertation is centered on allosteric investigations of lipoxygenase (LO). Human lipoxygenases (hLO) are an important class of metallo-enzymes involved in regulating inflammation response by initiated oxylipid signaling cascades via their hydroperoxide metabolites of arachidonic acid (AA) and linoleic acid (LA). There is growing evidence demonstrating hLO involvement in many inflammatory diseases and a variety of cancer, making the LO family a suitable pharmacological target. Recent data has suggested the substrate specificity of these enzymes for either arachidonic acid or linoleic acid, may play a role in cancer progress since the LO metabolites of these fatty acids have different cellular responses. Therefore, determining the substrate specificity of these enzymes is critical in understanding there role in cancer progression.;This dissertation investigates the allostery of lipoxygenase using three distinct methods: substrate specificity studies, mechanistic studies and inhibition studies. Using a novel competitive substrate capture experiment which measures the simultaneous product formation of a two substrate enzyme assay, we have discovered an intricate product-feedback mechanism that differentially affects the substrate specificity of the 15-hLO isozymes. Probing the allostery using isopote effect experiments, we have demonstrated that allosteric binding can affect the rate-limiting contributions from the individual steps in the catalytic mechanism of 15-hLO, suggestive of a regulatory mechanism for substrate specificity. Finally, inhibition studies have demonstrated allosteric inhibitors not only suppress catalytic activity, but also affect substrate selectivity. These findings are significant for drug discovery, introducing a new approach for manipulating hLO activity in inflammatory diseases and cancer.
机译:本文的研究集中在脂氧合酶(LO)的变构研究上。人脂氧合酶(hLO)是一类重要的金属酶,通过其花生四烯酸(AA)和亚油酸(LA)的氢过氧化物代谢,通过起始的脂质信号传导级联反应来调节炎症反应。越来越多的证据表明hLO参与了许多炎症性疾病和各种癌症,使LO家族成为合适的药理学靶标。最新数据表明,这些酶对花生四烯酸或亚油酸的底物特异性可能在癌症进展中起作用,因为这些脂肪酸的LO代谢产物具有不同的细胞反应。因此,确定这些酶的底物特异性对于了解其在癌症进展中的作用至关重要。本论文采用三种不同的方法研究了脂氧合酶的变构作用:底物特异性研究,机理研究和抑制研究。使用一种新颖的竞争性底物捕获实验来测量两种底物酶测定法同时形成的产物,我们发现了一种复杂的产物反馈机制,该机制不同地影响15-hLO同工酶的底物特异性。使用等渗效应实验探查变构,我们证明了变构结合可以影响15-hLO催化机制中各个步骤的限速作用,提示底物特异性的调控机制。最后,抑制研究表明,变构抑制剂不仅抑制催化活性,而且还影响底物的选择性。这些发现对于药物发现具有重要意义,为控制炎症性疾病和癌症中的hLO活性提供了一种新方法。

著录项

  • 作者

    Wecksler, Aaron Thomas.;

  • 作者单位

    University of California, Santa Cruz.;

  • 授予单位 University of California, Santa Cruz.;
  • 学科 Chemistry Biochemistry.
  • 学位 Ph.D.
  • 年度 2009
  • 页码 179 p.
  • 总页数 179
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号